Viewing nowBisoprolol Tablets (Bisoprolol Fumarate)
Bisoprolol Fumarate 5mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

MFDS item code 200401383 · Notified 2004.09.09 · Insurance code 650300700
Treatment of hypertension, stable chronic heart failure with left ventricular systolic dysfunction, and angina
This medication is used to treat hypertension and angina. It is also effective for treating stable chronic heart failure with reduced left ventricular systolic function, often used in combination with ACE inhibitors and diuretics as needed to enhance efficacy. Therefore, it serves as a medication that aids in blood pressure control and improvement of heart function.
Take in the morning on an empty stomach or with breakfast, without chewing, with a drink. 1. Hypertension, angina pectoris Adults Administer bisoprolol fumarate 5-10mg orally once daily. 5mg is sufficient for mild cases, while 10mg should be administered for severe cases. In special cases, up to 20mg per day may be administered. Adjust the dose as appropriate according to age and symptoms. Patients with hepatic or renal impairment Dose adjustment is generally not necessary in patients with hypertension or angina pectoris who have mild or moderate hepatic or renal impairment. Do not administer more than 10mg per day to patients with severe hepatic impairment or renal impairment (creatinine clearance < 20ml/min). 2. Stable chronic heart failure Adults Gradually increase the dose of bisoprolol fumarate as follows and administer orally once daily. Start treatment with this medicine when the patient is stable and has no acute symptoms of heart failure. Dose titration The initial dose of this medicine is 1.25mg once daily. Monitor tolerability and gradually increase the dose in the following order, allowing an interval of at least 2 weeks at each step: 2.5mg, 3.75mg, 5mg, 7.5mg, 10mg. The maintenance dose is 10mg once daily. The recommended maximum daily dose is 10mg once daily. During dose titration, closely monitor the patient's condition, including blood pressure and heart rate, and any worsening of heart failure symptoms. Dose adjustment during treatment If the maximum recommended dose is poorly tolerated, consider gradually reducing the dose. If transient worsening of heart failure symptoms, hypotension, or bradycardia occurs, adjustment of the dose of concomitant medicines is recommended. Temporary dose reduction or discontinuation of this medicine may be required if necessary. Once heart failure symptoms have stabilized, consider restarting this medicine or increasing the dose. Because abrupt discontinuation of this medicine may cause acute worsening of heart failure symptoms, gradual dose reduction is recommended. Treatment of stable chronic heart failure with this medicine is generally long-term. Patients with hepatic or renal impairment Pharmacokinetic information is unavailable for patients with chronic heart failure and these conditions; therefore, use particular caution when titrating the dose in these patients. Elderly patients Dose adjustment is not necessary.
Children Use of this medicine is not recommended in children because there is no experience with its use in this population.
This medication has not been used in patients with certain diseases or conditions among heart failure patients, so caution is needed. In particular, patients with type 1 insulin-dependent diabetes, severe renal or hepatic impairment, restrictive cardiomyopathy, significant valvular heart disease, recent myocardial infarction, and congenital heart disease should use this medication carefully. Patients with bronchial asthma or chronic obstructive pulmonary disease should use it with a bronchodilator, and asthmatic patients may need additional treatment due to increased airway resistance. This medication may increase hypersensitivity reactions to allergens, and adrenergic treatment may not always be effective. In patients with psoriasis or a history of psoriasis, the risks and benefits of this medication should be carefully considered before administration. Patients with pheochromocytoma should receive an alpha-blocker before using this medication. Caution is required since symptoms of hyperthyroidism may be masked by this medication, and regular examinations are needed at the beginning of treatment. Stopping this medication suddenly may worsen heart conditions; thus, particularly in patients with ischemic heart disease, it should be tapered off gradually. It should not be used in patients with diabetic ketoacidosis, severe bradycardia, cardiogenic shock, right heart failure due to pulmonary hypertension, acute heart failure, severe hypotension, severe peripheral circulatory disorders, dysautonomia syndrome, pregnant women, and women of childbearing potential, as well as patients with severe asthma. Patients with bronchial asthma, congestive heart failure, difficult-to-control diabetes, severe liver and kidney dysfunction, concurrent anesthesia, and those undergoing desensitization therapy should be given this medication cautiously. During treatment with this medication, various side effects such as bradycardia, decreased blood pressure, worsening heart failure, dizziness, headache, gastrointestinal symptoms, weakness, and fatigue may occur, so consultation with healthcare personnel is advised if symptoms arise. Long-term administration requires regular testing of heart function and liver and kidney function; dosage adjustments may be needed, especially if bradycardia or hypotension occurs. Due to numerous interactions with other medications, it is essential to inform healthcare personnel of all medications being taken, especially with calcium channel blockers and centrally acting antihypertensives. Pregnant women or those who may become pregnant should avoid taking this medication and breastfeeding women should also avoid its use or stop breastfeeding. The safety of this medication in children has not been established, so its use is not recommended. In the elderly, treatment should start at a low dose with close monitoring of the condition. Caution is required when driving or operating machinery due to individual variability, and extra care should be taken at the beginning of treatment or when changing medications. In cases of overdose, severe bradycardia, hypotension, bronchospasm, and worsening heart failure may occur, necessitating immediate medical attention and appropriate treatment. This medication should be kept out of the reach of children and stored in its original container to prevent degradation in quality or misuse.
Bradycardia, worsening of heart failure, coldness or paralysis of the extremities, hypotension, dizziness, headache, nausea, vomiting, diarrhea, constipation, weakness, fatigue, atrioventricular conduction disorder, orthostatic hypotension, sleep disorders, depression, bronchospasm, muscular atrophy and spasms, nightmares, hallucinations, decreased tear production, hearing impairment, allergic rhinitis, hypersensitivity reactions (itching, redness, rash), hepatitis, sexual dysfunction, conjunctivitis, worsening of psoriasis or triggering of psoriatic rashes, hair loss, fainting
Not everyone experiences these, and they can vary from person to person.
This medication can be sensitive to air or moisture and should be stored in a tightly closed container. It is advisable to maintain a storage temperature between 1°C and 30°C. This will help to preserve the effectiveness and safety of the medication over time.
A light yellow film-coated tablet in a heart shape, convex on both sides with a score line on one side.
30 tablets/bottle, 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowBisoprolol Fumarate 5mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

Bisoprolol Fumarate 5mg
Tablet · Prescription medication
Merck Co., Ltd.

Bisoprolol Fumarate 2.5mg
Tablet · Prescription medication
Merck Co., Ltd.

Bisoprolol Fumarate 5mg
Tablet · Prescription medication
Celix Co., Ltd.

Bisoprolol Fumarate 5mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

Bisoprolol Fumarate 5mg
Tablet · Prescription medication
Samchundang Pharmaceutical Co., Ltd.

Bisoprolol Fumarate 5mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Bisoprolol Fumarate 5mg
Tablet · Prescription medication
Ellison Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.